ProRx LLC is recalling 38,853 vials of compounded Semaglutide and Tirzepatide injections because they may not be sterile. The recall includes various strengths and sizes of multidose vials distributed in Texas and Utah. A lack of sterility in an injectable medication can lead to serious infections at the injection site or throughout the body. Consumers should contact their healthcare provider or pharmacist regarding these medications and avoid using any remaining product.
The medications were produced without adequate assurance of sterility, which could allow bacteria or other contaminants to be present in the vials. Injecting a non-sterile product can cause localized infections, abscesses, or life-threatening systemic infections.
You have 2 options:
Mfd by: ProRx, 619 Jeffers Cir, Exton, PA 19341
Mfd by: ProRx, 619 Jeffers Cir, Exton, PA 19341
Mfd by: ProRx, 619 Jeffers Cir, Exton, PA 19341
Mfd by: ProRx, 619 Jeffers Cir, Exton, PA 19341
Mfd by: ProRx, 619 Jeffers Cir, Exton, PA 19341
Mfd by: ProRx, 619 Jeffers Cir, Exton, PA 19341
Mfd by: ProRx, 619 Jeffers Cir, Exton, PA 19341
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.